Concordia and AstraZeneca are delighted to announce the release of Repaying the Debt to Women: Breast Cancer Policy Report. At the 2025 Concordia Annual Summit, AstraZeneca, in partnership with Concordia, Siemens Healthineers, Merck, and Movement Health, brought together a multidisciplinary group of international experts to examine the use and implementation of the newly developed Breast Cancer Care Quality Index (BCCQI).
Experts participated in five cross-sector roundtables to explore how the BCCQI can be integrated into policy and healthcare systems to improve access to care and health equity for women worldwide in order to close the Breast Cancer care gap. Building upon the first AstraZeneca Breast Cancer Care Luncheon, hosted at the 2024 Concordia Annual Summit, this report outlines a summary of roundtable takeaways, and includes policy recommendations and key calls to action in an attempt to provide a roadmap to translate frameworks like the BCCQI into action that delivers early detection and diagnosis, equitable treatment, and improved outcomes.
